Bioregenx annual net debt
2021
2022
2023
2024
2025
Bioregenx Net Debt Growth & History (BRGX)
Bioregenx's net debt was $1.1M for fiscal 2025.
View full Bioregenx company overviewBioregenx annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.1M | $36,175 | +3.35% |
| 2024 | 2024-12-31 | $1.1M | $1.0M | +1347.05% |
| 2023 | 2023-12-31 | $74,598 | −$124,726 | −62.57% |
| 2022 | 2022-12-31 | $199,324 | $23,682 | +13.48% |
| 2021 | 2021-12-31 | $175,642 | — | — |
Bioregenx quarterly net debt
Q4.21
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $2.1M | $38,038 | +1.83% |
| Q4 2025 | 2025-12-31 | $1.1M | $36,175 | +3.35% |
| Q3 2025 | 2025-09-30 | $2.2M | — | — |
| Q2 2025 | 2025-06-30 | $2.1M | — | — |
| Q1 2025 | 2025-03-31 | $2.1M | $1.6M | +377.59% |
| Q4 2024 | 2024-12-31 | $1.1M | $1.0M | +1347.05% |
| Q1 2024 | 2024-03-31 | $435,842 | $235,842 | +117.92% |
| Q4 2023 | 2023-12-31 | $74,598 | −$124,726 | −62.57% |
| Q3 2023 | 2023-09-30 | $199,242 | — | — |
| Q2 2023 | 2023-06-30 | $200,000 | — | — |
| Q1 2023 | 2023-03-31 | $200,000 | — | — |
| Q4 2022 | 2022-12-31 | $199,324 | $23,682 | +13.48% |
| Q4 2021 | 2021-12-31 | $175,642 | — | — |
Bioregenx net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioregenx's net debt increased from $175,642 to $1.1M, a change of $940,006. The latest reported quarter, Q1 2026, shows $2.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx source filings ↗